First Time Loading...

Zoetis Inc
NYSE:ZTS

Watchlist Manager
Zoetis Inc Logo
Zoetis Inc
NYSE:ZTS
Watchlist
Price: 159.7 USD 0.81% Market Closed
Updated: Apr 30, 2024

Zoetis Inc
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Zoetis Inc
Operating Income Peer Comparison

Comparables:
JNJ
BMY
PFE
MRK
LLY

Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
Zoetis Inc
NYSE:ZTS
Operating Income
$3.1B
CAGR 3-Years
11%
CAGR 5-Years
10%
CAGR 10-Years
14%
Johnson & Johnson
NYSE:JNJ
Operating Income
$23.4B
CAGR 3-Years
3%
CAGR 5-Years
3%
CAGR 10-Years
3%
Bristol-Myers Squibb Co
NYSE:BMY
Operating Income
$10.8B
CAGR 3-Years
22%
CAGR 5-Years
7%
CAGR 10-Years
13%
Pfizer Inc
NYSE:PFE
Operating Income
$13.1B
CAGR 3-Years
4%
CAGR 5-Years
8%
CAGR 10-Years
-3%
Merck & Co Inc
NYSE:MRK
Operating Income
$4.1B
CAGR 3-Years
-28%
CAGR 5-Years
-19%
CAGR 10-Years
-7%
Eli Lilly and Co
NYSE:LLY
Operating Income
$10.3B
CAGR 3-Years
15%
CAGR 5-Years
12%
CAGR 10-Years
6%

See Also

What is Zoetis Inc's Operating Income?
Operating Income
3.1B USD

Based on the financial report for Dec 31, 2023, Zoetis Inc's Operating Income amounts to 3.1B USD.

What is Zoetis Inc's Operating Income growth rate?
Operating Income CAGR 10Y
14%

Over the last year, the Operating Income growth was 5%. The average annual Operating Income growth rates for Zoetis Inc have been 11% over the past three years , 10% over the past five years , and 14% over the past ten years .